A greater understanding of the functional role of S100A10 in ovarian cancer cells could lead to the development of effective strategies to target S100A10 and annexin A2, inhibit progression, and overcome chemotherapy resistance in ovarian cancer patients. The gene discussed is ANXA2; the disease is ovarian carcinoma.